All Reports
GEHC·HealthcareBUY

GE HealthCare Technologies Inc.

Benjamin Evensen·November 14, 2026

Price Target

$97.76

Upside

+17.8%

Investment Thesis

We initiate GE HealthCare with a BUY and a blended target of USD 97.76, about 17.8% upside. The stock trades at 15.1x our FY2027E adjusted EPS versus a peer median of 16.8x, and at 12.7x trailing EBITDA versus 14.4x. Shares fell 13% in April on a guidance cut but have recovered roughly 40% on strong Q2 and Q3 results. Even so, the market has not fully priced in easing cost pressures and growth in the higher-margin PDx business.

Full Report

The complete report includes a DCF valuation, comparable company analysis, and full investment thesis with risk factors.

Report Details

AnalystBenjamin Evensen
PublishedNovember 14, 2026
SectorHealthcare
RatingBUY
Price Target$97.76
Current Price$83.02

For educational purposes only. Not investment advice. Price targets reflect analyst estimates as of the publication date.